Keros Therapeutics (KROS) PT Raised to $102 at Guggenheim
Tweet Send to a Friend
(Updated - December 5, 2024 7:07 AM EST)
Guggenheim analyst Vamil Divan raised the price target on Keros Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Vamil Divan raised the price target on Keros Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
